Massachusetts Clinical Trials

Recruiting studies in Massachusetts

• Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
  NCT06095583Limited-stage Small Cell Lung Cancer (LS-SCLC)Boston, MA
• A Clinical Trial Assessing the Safety and Effectiveness of the DurAVR® THV System
  NCT07194265Severe Aortic StenosisBoston, MA
• A Clinical Study to Evaluate the Safety and Efficacy of ETX101 in Infants and Children With SCN1A-Positive Dravet Syndrome
  NCT05419492Dravet SyndromeBoston, MA
• Evaluation of PLG0206 in Prevention of Recurrent Infection in Patients Undergoing Debridement, Antibiotics, and Implant Retention (DAIR) for Treatment of a Periprosthetic Joint Infection (PJI) Following Knee Arthroplasty
  NCT07214311Prosthetic-joint InfectionBoston, MA
• A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in Adults
  NCT06625060Episodic MigraineFoxborough, MA
• Valproate for the Treatment of Residual Amblyopia
  NCT07226141AmblyopiaBoston, MA
• Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma
  NCT06172296Ganglioneuroblastoma, NodularBoston, MA
• Chemotherapy Combined With Immunotherapy Versus Immunotherapy Alone for Older Adults With Stage IIIB-IV Lung Cancer, The ACHIEVE Trial
  NCT06096844Advanced Lung Non-Small Cell CarcinomaBoston, MA
• A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
  NCT06742723Chronic Kidney Disease and HypertensionBoston, MA
• A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
  NCT06623422Carcinoma, Non-Small-Cell LungBoston, MA
• A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
  NCT05519085Relapsed or Refractory Multiple MyelomaBoston, MA
• Testing Low-Dose Common Chemotherapy (Liposomal Doxorubicin) in Combination With an Anti-Cancer Drug, Peposertib, in Advanced Sarcoma
  NCT05711615Metastatic Dedifferentiated LiposarcomaBoston, MA

See all 3,044 recruiting Massachusetts trials →

Clinical trials by Massachusetts metro

• Boston

Popular conditions in Massachusetts

• Breast Cancer
• Prostate Cancer
• Lung Cancer
• Colorectal Cancer
• Obesity
• Type 2 Diabetes
• Depression
• Alzheimer Disease
• Heart Failure
• Multiple Sclerosis
• Rheumatoid Arthritis
• Asthma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer
• Pancreatic Cancer
• Pancreatic Ductal Adenocarcinoma

Frequently asked questions

How do I find clinical trials in Massachusetts?

Corterve aggregates actively recruiting clinical trials with sites in Massachusetts from the public ClinicalTrials.gov registry. Browse the studies on this page or take a free health assessment to find trials you may qualify for.

Are clinical trials in Massachusetts free to join?

Study participation is typically free — sponsors cover the investigational treatment and study-related visits, and many studies compensate participants for time and travel. Details vary by study.

What kinds of clinical trials are available in Massachusetts?

Massachusetts research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.